Annexon Stock (NASDAQ: ANNX) stock price, news, charts, stock research, profile.
Open | $4.760 |
Close | $4.830 |
Volume / Avg. | 1.575M / 1.922M |
Day Range | 4.700 - 5.095 |
52 Wk Range | 1.570 - 8.400 |
Market Cap | $470.779M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 10.09% |
Days to Cover | 3.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Annexon (NASDAQ: ANNX) through any online brokerage.
Other companies in Annexon’s space includes: Cabaletta Bio (NASDAQ:CABA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
The latest price target for Annexon (NASDAQ: ANNX) was reported by Wells Fargo on Wednesday, May 15, 2024. The analyst firm set a price target for 10.00 expecting ANNX to rise to within 12 months (a possible 96.30% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Annexon (NASDAQ: ANNX) is $5.0943 last updated May 31, 2024 at 5:35 PM EDT.
There are no upcoming dividends for Annexon.
Annexon’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Annexon.
Annexon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.